insights_auto
Why is FATE down 4.48%?
Dive Deeperchevron_right
FATE:NASDAQ
Fate Therapeutics Inc
$1.28
arrow_downward
-4.48%(-0.060) 1D
Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for FATE...
Open
$1.32
High
$1.33
Low
$1.21
Mkt. cap
155.61M
Avg. vol.
1.46M
Volume
1.81M
52-wk high
$3.23
52-wk low
$0.95
EPS
-$1.03
Beta
2.65
Shares outstanding
121.57M
No. of employees
161
Open
$1.32
High
$1.33
Low
$1.21
Mkt. cap
155.61M
Avg. vol.
1.46M
Volume
1.81M
52-wk high
$3.23
52-wk low
$0.95
EPS
-$1.03
Beta
2.65
Shares outstanding
121.57M
No. of employees
161
News stories
From web sources and news partners
Howl.Link
·
8 hours ago
Weekly Market Outlook – Not A Decisive Reversal Effort - TalkMarkets
صحيفة مال
·
13 hours ago
Nasdaq Records Best Weekly Performance Since August
Bloomberg.com
·
10 hours ago
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
The Motley Fool
·
9 hours ago
Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years
About Fate Therapeutics Inc
CEOScott Wolchko
Employees161
Founded2007
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitefatetherapeutics.com